Overview

Study in Patients With Asthma

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.
Phase:
Phase 2
Details
Lead Sponsor:
Dey
Treatments:
Formoterol Fumarate